Eduardo Arranz

Dr. Eduardo Arranz


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ALAlberto J. León
Alberto J. León
EGEmma Gómez
Emma Gómez
JGJose A. Garrote
Jose A. Garrote
DBDavid Bernardo
David Bernardo
ABAsterio Barrera
Asterio Barrera
EAEduardo Arranz
Eduardo Arranz
Intestinal alterations in IBD are triggered and maintained by an overexpression of proinflammatory cytokines. Additionally, increased immune activation has been found in the adjacent intestinal areas without displaying any apparent histological alterations, however, the regulatory environment is not well established. Biopsy specimens from patients with ulcerative colitis (UC) and Crohn's disease (CD), from both affected and unaffected areas, and also from a group of colonic biopsies from healthy controls, were included in our study. Cytokines and markers of mucosal damage were analyzed by real-time PCR, and some of the results confirmed by western-blot and ELISA. Levels of IFNγ, TNFα, IL-6, IL-15, IL-18, and IL-23 were increased (above healthy controls) in both affected and unaffected areas from IBD. IL-1β, IL-6, IL-12, and IL-27 were higher in affected areas compared to unaffected ones in UC but not CD. In general, a correlation was observed between mRNA levels of these cytokines and both iNOS and Granzyme B. SOCS-2 and SOCS-3 were also increased in the affected areas. In conclusion, the unaffected areas from IBD show increased levels of a restricted set of cytokines that may exert immune activating roles in these areas without being able to trigger tissue damage.

9 September 2008 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
DBDavid Bernardo
David Bernardo
JGJose A. Garrote
Jose A. Garrote
YAY. Allegretti
Y. Allegretti
ALA. León
A. León
EGE. Gómez
E. Gómez
EAEduardo Arranz
Eduardo Arranz
The IL-15 triggering effect of gliadin is not exclusive to coeliac disease (CD) patients, whereas the secondary response is CD specific. We have studied the expression of the IL-15 receptor, and the IL-15 response upon stimulation, in non-CD and CD patients, and the possible existence of a lower immunological threshold in the latter. Forty-two CD patients (20 on a gluten-containing diet, GCD, and 22 on gluten-free diet, GFD) and 24 non-CD healthy individuals were studied. IL15Rα mRNA expression, and tissue characterization, were assayed in the duodenum. Biopsies from six CD patients on GFD and 10 non-CD individuals were studied in vitro using organ culture in basal conditions, as well as after IL-15 stimulation discarding basal IL-15 production. Secretion of immune mediators was measured in the culture supernatants. IL15Rα mRNA expression was increased in CD patients, as compared with non-CD controls (on GFD P = 0·0334, on GCD P = 0·0062, respectively), and confirmed also by immunofluorescence. No differences were found between CD patients on GFD and on GCD. After in vitro IL-15 stimulation, IL15Rα expression was only triggered in non-CD controls (P = 0·0313), though it remained increased in CD patients. Moreover, IL-15 induced a more intense immunological response in CD patients after triggering the production of both nitrites and IFNγ (P = 0·0313, P = 0·0313, respectively). Gliadin-induced IL15 has a lower response threshold in CD patients, leading to the production of other immune mediators and the development of the intestinal lesion, and thus magnifying its effects within the CD intestine.

22 May 2007 in Gut
Verified
Journal Article
Closed access
PDF file
DBDavid Bernardo
David Bernardo
JGJose A. Garrote
Jose A. Garrote
LFLuis Fernández-Salazar
Luis Fernández-Salazar
SRS Riestra
S Riestra
EAEduardo Arranz
Eduardo Arranz
To test the hypothesis, biopsy cultures were taken from at least three patients with CD who are on a gluten-free diet (GFD) and three patients without …

13 October 2006 in Clinical and Experimental Immunology
Verified
Journal Article
Open access
PDF file
ALA. J. León
A. J. León
JGJose A. Garrote
Jose A. Garrote
ABA. Blanco-Quirós
A. Blanco-Quirós
CCC. Calvo
C. Calvo
LFLuis Fernández-Salazar
Luis Fernández-Salazar
EAEduardo Arranz
Eduardo Arranz
Dietary gluten induces an early response in the intestine of coeliac disease patients (CD), within a few hours, and this is driven by high levels of proinflammatory cytokines, including IFNγ and IL-15, as has been thoroughly shown by gluten stimulation of biopsy explants. Our aim was to identify the immune mediators involved in the long-standing inflammation in untreated CD patients at diagnosis. mRNA and protein levels of TNFα, IL-12(p35), IL-12(p40), IL-15, IL-18 and IL-23(p19) were quantified in biopsies from active CD patients, CD patients on a gluten-free diet (GFD), healthy controls, and patients with non-CD inflammation and mild histological changes in the intestine. Biopsies from CD patients on a GFD were also stimulated in vitro with gliadin, and protein expression of IL-15 and IL-18 was analysed. Levels of IL-12 and IL-23 mRNA are nearly absent, and TNFα levels remain unchanged among different groups. Both the active and inactive forms of IL-18 protein have been found in all samples from active CD, and protein expression was only localized within the crypts. Levels of IL-15 mRNA remain unchanged, and protein expression, localized within the lamina propria, is found in a small number of samples. In vitro stimulation with gluten induces the expression of IL-15 and IL-18. In active CD, the early response following gluten intake characterized by high IFNγ levels is driven by IL-18, and probably IL-15, and this alternates with periods of long-standing inflammation with moderate IFNγ levels, maintained by IL-18 alone.

1 March 2002 in The Lancet
Verified
Journal Article
Closed access
LSLuis Sorell
Luis Sorell
JGJose A. Garrote
Jose A. Garrote
BABoris Acevedo
Boris Acevedo
EAEduardo Arranz
Eduardo Arranz

1 November 2017 in Cytokine
Verified
Journal Article
Closed access
CECelia Escudero-Hernández
Celia Escudero-Hernández
LPLeticia Plaza-Izurieta
Leticia Plaza-Izurieta
JGJose A. Garrote
Jose A. Garrote
JBJose Ramon Bilbao
Jose Ramon Bilbao
EAEduardo Arranz
Eduardo Arranz